Regulatory press release8/1/2024, 6:45 AMThe subscription period in Cyxone's rights issue starts today
Regulatory press release7/23/2024, 6:30 AMCyxone: The board decides on a rights issue of a maximum of approximately SEK 23 million to finance continued development of rabeximod and T20K
Press release11/20/2023, 8:22 AMCyxone welcomes a renewed engagement by Professor Rikard Holmdahl as Scientific Advisor
Regulatory press release10/9/2023, 6:38 AMCyxone receives Intention to Grant from the European Patent Office for a unitary patent of T20K
Regulatory press release8/29/2023, 5:03 PMCyxone revises strategy for commercial alignment targeting valuable market opportunities
Press release5/31/2023, 12:00 PMCyxone receives Intention to Grant from the European Patent Office for the divisional patent of T20K